These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 438546

  • 1. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis.
    Siebert WT, Moreland N, Williams TW.
    J Infect Dis; 1979 Apr; 139(4):452-7. PubMed ID: 438546
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal action of nafcillin, vancomycin, and three cephalosporins against nafcillin-susceptible and nafcillin-resistant coagulase-negative staphylococci.
    Mordenti JJ, Davis RH, Lammel CJ, Brooks GF.
    Diagn Microbiol Infect Dis; 1986 May; 5(1):1-8. PubMed ID: 3635453
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis.
    Ein ME, Smith NJ, Aruffo JF, Heerema MS, Bradshaw MW, Williams TW.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):655-9. PubMed ID: 260880
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G, Leaños-Miranda BE, Vilchis-Pérez M, Solórzano-Santos F.
    Ann Clin Microbiol Antimicrob; 2006 Oct 12; 5():25. PubMed ID: 17034644
    [Abstract] [Full Text] [Related]

  • 5. Activity of cephalosporins against coagulase-negative staphylococci.
    Chin NX, Neu NM, Neu HC.
    Diagn Microbiol Infect Dis; 1990 Oct 12; 13(1):67-9. PubMed ID: 2331853
    [Abstract] [Full Text] [Related]

  • 6. Population analysis of susceptibility to methicillin, vancomycin, and three cephalosporines in two methicillin-resistant strains of Staphylococcus epidermidis.
    Hansen BG.
    Acta Pathol Microbiol Immunol Scand B; 1983 Aug 12; 91(4):279-84. PubMed ID: 6556002
    [Abstract] [Full Text] [Related]

  • 7. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
    Uete T, Matsuo K.
    Jpn J Antibiot; 1995 Mar 12; 48(3):402-8. PubMed ID: 7752453
    [Abstract] [Full Text] [Related]

  • 8. Studies on clinical isolates of coagulase-negative staphylococci resistant to methicillin. Evidence of cross-resistance between methicillin and cephalothin.
    Hansen-Nord M, Gahrn-Hansen B, Siboni K.
    APMIS; 1988 Feb 12; 96(2):133-40. PubMed ID: 3345258
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C, Libke RD, Engelking ER, Clarke JT, Kirby MM.
    J Infect Dis; 1975 Mar 12; 131(3):291-4. PubMed ID: 1039311
    [Abstract] [Full Text] [Related]

  • 10. Cephalothin and cefazolin in vitro antibacterial activity and pharmacokinetics in dogs.
    Petersen SW, Rosin E.
    Vet Surg; 1995 Mar 12; 24(4):347-51. PubMed ID: 7571387
    [Abstract] [Full Text] [Related]

  • 11. Cephalosporin susceptibility of methicillin-resistant, coagulase-negative staphylococci.
    Menzies RE, Cornere BM, MacCulloch D.
    Antimicrob Agents Chemother; 1987 Jan 12; 31(1):42-5. PubMed ID: 3646002
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of flomoxef and cefazolin in combination with vancomycin.
    Simon C, Simon M.
    Infection; 1991 Jan 12; 19 Suppl 5():S276-8. PubMed ID: 1783443
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of antibiotic combinations including rifampin against methicillin-resistant Staphylococcus epidermidis: in vitro and in vivo studies.
    Archer GL, Johnston JL, Vazquez GJ, Haywood HB.
    Rev Infect Dis; 1983 Jan 12; 5 Suppl 3():S538-42. PubMed ID: 6556710
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic tolerance of Staphylococcus epidermidis.
    Watanakunakorn C.
    Scand J Infect Dis; 1985 Jan 12; 17(1):59-61. PubMed ID: 3992207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.
    Laverdiere M, Peterson P, Verhoef J, Williams DN, Sabath LD.
    J Infect Dis; 1978 Mar 12; 137(3):245-50. PubMed ID: 632623
    [Abstract] [Full Text] [Related]

  • 17. In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Lozniewski A, Lion C, Mory F, Weber M.
    J Antimicrob Chemother; 2001 Jan 12; 47(1):83-6. PubMed ID: 11152435
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.